2021
DOI: 10.1007/s40261-021-01090-x
|View full text |Cite
|
Sign up to set email alerts
|

The Intraoperative Median Effective Dose of Oxytocin for Preventing Uterine Atony in Parturients with a Prior History of Caesarean Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…Clinical research has also shown that elderly parturients required more oxytocin for preventing uterine atony (Bobrowski and Bottoms, 1995;Wei et al, 2020). Our previous study estimated the ED50 of oxytocin was greater in the parturients with a history of prior caesarean delivery than in the parturients without a history of prior caesarean delivery (Wei et al, 2021). Therefore, uterine scarring and advanced maternal age may be responsible for the increased requirements of oxytocin in elderly parturients with a prior history of CD.…”
Section: Figurementioning
confidence: 91%
“…Clinical research has also shown that elderly parturients required more oxytocin for preventing uterine atony (Bobrowski and Bottoms, 1995;Wei et al, 2020). Our previous study estimated the ED50 of oxytocin was greater in the parturients with a history of prior caesarean delivery than in the parturients without a history of prior caesarean delivery (Wei et al, 2021). Therefore, uterine scarring and advanced maternal age may be responsible for the increased requirements of oxytocin in elderly parturients with a prior history of CD.…”
Section: Figurementioning
confidence: 91%
“…Of note, all studies found an oxytocin bolus dose requirement well under 5 units (and generally under 1 unit). A randomized controlled trial of oxytocin bolus dosing at the time of cesarean delivery showed that patients with a history of prior cesarean birth required a higher oxytocin dose (0.95 units [95% confidence interval (CI) 0.82–1.08] vs. 0.55 units [95% CI 0.38–0.73], P < 0.001) [15]. Similarly, when patients with preeclampsia receiving magnesium sulfate were compared to nonhypertensive patients (not on magnesium) at the time of cesarean, patients on magnesium required significantly higher oxytocin doses and suffered significantly more side effects and hypotension as a result [16].…”
Section: Treatmentmentioning
confidence: 99%